...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Share value

I noticed that on Nov 9, a price of 0.76 US was applied to my Zenith shares. Previously it showed a price of 1.00 with no value attached.

 

TD told me that they had received the price information from an independent source but had no information.

1
Nov 22, 2017 04:19PM
1
Nov 25, 2017 08:11AM
Share
New Message
Please login to post a reply